SEC Form 4 · accession 0001209191-15-000284
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Dougherty
Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 2, 2015 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $23.51 | Jan 1, 2015 | A | 15,000 | A | — | Dec 31, 2024 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (Right to Buy)F2 | $7.86 | holding | — | — | — | — | Jun 2, 2023 | Common Stock | 25,000 | 25,000 | D |
| Stock Option (Right to Buy)F3 | $13.10 | holding | — | — | — | — | Jan 7, 2024 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning after 01/01/2015.
- F2The option vests according to the following schedule: 1/12th of the shares vest at the end of each month, beginning 06/30/13.
- F3The option vests according to the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning after 01/01/2014.